EIF6 and non-small cell lung carcinoma: Our TCGA data set indicated eIF6 overexpression reduced patients overall survival in HCC, which was in accord with existing results from NSCLC and OV [21, 23], highly suggesting that it was a predictor for overall survival in HCC.